STOCK TITAN

Aurora Cannabis Inc - ACB STOCK NEWS

Welcome to our dedicated news page for Aurora Cannabis (Ticker: ACB), a resource for investors and traders seeking the latest updates and insights on Aurora Cannabis.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Aurora Cannabis's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Aurora Cannabis's position in the market.

Rhea-AI Summary
Aurora Cannabis Inc. (ACB) Achieves Quarterly Net Revenue of $75.1 Million with Strong YoY Growth Across All Business Units. The company delivered its third sequential quarter of positive adjusted EBITDA, supported by Bevo's record quarterly revenue. Cash used in operating activities reduced by $15.5 million YoY, re-affirming the target of positive free cash flow in calendar year 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.49%
Tags
none
-
Rhea-AI Summary
Aurora Cannabis Inc. has announced that it will host a conference call to discuss its first quarter fiscal year 2024 results on August 10, 2023. The call will be hosted by the CEO and CFO of the company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.91%
Tags
conferences earnings
Rhea-AI Summary
Aurora Cannabis Inc. (ACB) announced the sale of its Medicine Hat, Alberta facility, the Aurora Sun Facility, to Bevo Farms Ltd. for up to $15 million. The sale aims to improve Aurora's cash flow and support Bevo's business expansion. Bevo, a subsidiary of Bevo Agtech Inc., will benefit from the acquisition, and the transaction is expected to accelerate Bevo's revenue and earnings. The sale will also reduce Aurora's annual carrying costs by approximately $2 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.85%
Tags
Rhea-AI Summary
Aurora Cannabis Inc. has scheduled a conference call to discuss its third quarter and full fiscal year 2023 results on June 14, 2023. The company will report its financial results before the opening of markets that same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.74%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.06%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.04%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Aurora Cannabis Inc

NYSE:ACB

ACB Rankings

ACB Stock Data

323.18M
54.39M
6.96%
9.31%
Medicinal and Botanical Manufacturing
Manufacturing
Link
Canada
Edmonton

About ACB

aurora is a canadian company and licensed producer of artisanal medical marijuana pursuant to the marihuana for medical purposes regulations. we ensure the highest quality, reliability, and safety of our products through advanced cultivation techniques carried out in our 55,200 square foot expandable state-of-the-art production facility in alberta, canada. aurora’s wholly-owned subsidiary, australis capital inc., seeks to be an active participant in the u.s. cannabis market.